A detailed history of Btc Capital Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Btc Capital Management, Inc. holds 70,937 shares of GILD stock, worth $6.4 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
70,937
Previous 75,519 6.07%
Holding current value
$6.4 Million
Previous $5.18 Million 14.75%
% of portfolio
0.53%
Previous 0.48%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$66.59 - $83.99 $305,115 - $384,842
-4,582 Reduced 6.07%
70,937 $5.95 Million
Q2 2024

Jul 19, 2024

SELL
$63.15 - $72.88 $70,980 - $81,917
-1,124 Reduced 1.47%
75,519 $5.18 Million
Q1 2024

Apr 10, 2024

BUY
$71.58 - $87.29 $211,232 - $257,592
2,951 Added 4.0%
76,643 $5.61 Million
Q3 2023

Oct 17, 2023

SELL
$73.94 - $80.67 $10,943 - $11,939
-148 Reduced 0.2%
73,692 $5.52 Million
Q2 2023

Jul 11, 2023

BUY
$76.01 - $86.7 $114,623 - $130,743
1,508 Added 2.08%
73,840 $5.69 Million
Q1 2023

Apr 06, 2023

SELL
$77.31 - $88.08 $145,420 - $165,678
-1,881 Reduced 2.53%
72,332 $6 Million
Q4 2022

Jan 27, 2023

SELL
$62.32 - $89.47 $515,947 - $740,722
-8,279 Reduced 10.04%
74,213 $0
Q3 2022

Oct 17, 2022

BUY
$59.54 - $68.01 $565,213 - $645,618
9,493 Added 13.0%
82,492 $5.09 Million
Q2 2022

Jul 25, 2022

SELL
$57.72 - $65.01 $539,797 - $607,973
-9,352 Reduced 11.36%
72,999 $4.51 Million
Q1 2022

May 06, 2022

SELL
$57.92 - $72.58 $196,638 - $246,409
-3,395 Reduced 3.96%
82,351 $4.9 Million
Q4 2021

Feb 09, 2022

BUY
$64.88 - $73.64 $856,610 - $972,268
13,203 Added 18.2%
85,746 $6.23 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $262,027 - $282,699
3,871 Added 5.64%
72,543 $5.06 Million
Q2 2021

Aug 02, 2021

SELL
$63.47 - $69.35 $558,980 - $610,765
-8,807 Reduced 11.37%
68,672 $4.75 Million
Q1 2021

May 04, 2021

SELL
$60.0 - $68.46 $22,980 - $26,220
-383 Reduced 0.49%
77,479 $5 Million
Q4 2020

Jan 28, 2021

BUY
$56.65 - $64.55 $1.09 Million - $1.24 Million
19,263 Added 32.87%
77,862 $4.53 Million
Q3 2020

Oct 14, 2020

BUY
$62.1 - $78.08 $294,105 - $369,786
4,736 Added 8.79%
58,599 $3.7 Million
Q2 2020

Aug 04, 2020

BUY
$72.34 - $84.0 $191,990 - $222,936
2,654 Added 5.18%
53,863 $4.14 Million
Q1 2020

May 06, 2020

SELL
$62.63 - $80.22 $159,080 - $203,758
-2,540 Reduced 4.73%
51,209 $3.83 Million
Q4 2019

Feb 13, 2020

SELL
$61.62 - $67.78 $39,251 - $43,175
-637 Reduced 1.17%
53,749 $3.49 Million
Q3 2019

Oct 18, 2019

BUY
$62.51 - $69.0 $208,970 - $230,667
3,343 Added 6.55%
54,386 $3.45 Million
Q2 2019

Jul 26, 2019

BUY
$61.87 - $69.38 $3.16 Million - $3.54 Million
51,043 New
51,043 $3.45 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Btc Capital Management, Inc. Portfolio

Follow Btc Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btc Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Btc Capital Management, Inc. with notifications on news.